Linsidomine hydrochloride NEW
| Price | $48 | $81 | $156 |
| Package | 5mg | 10mg | 25mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-11-05 |
Product Details
| Product Name: Linsidomine hydrochloride | CAS No.: 16142-27-1 |
| Purity: 99.81% | Supply Ability: 10g |
| Release date: 2025/11/05 |
Product Introduction
Bioactivity
| Name | Linsidomine hydrochloride |
| Description | Linsidomine hydrochloride (SIN-1 chloride) is considered as a metabolite of moxidomine, with vasodilation, inhibition of platelet aggregation, and antiangina activity. In myocardial ischemia-reperfusion models, Linsidomine hydrochloride to reduce myocardial necrosis and reperfusion induced endothelial dysfunction is associated with the cavernosal mechanism of action involved in nitric oxide release. |
| In vitro | SIN-1 decreases myocardial necrosis and reperfusion-induced endothelial dysfunction in models of myocardial ischemia-reperfusion [1][2]. |
| In vivo | SIN-1 (chloride) is the active metabolite of molsidomine. SIN-1 (chloride) exhibits a potent vasorelaxant effect and inhibition of platelet aggregation.[1] SIN-1 (chloride) decreases myocardial necrosis and reperfusion-induced endothelial dysfunction in models of myocardial ischemia-reperfusion.[2] |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 22.5 mg/mL (108.9 mM), Sonication and heating to 60℃ are recommended. H2O : 45.0 mg/mL (217.8 mM), Sonication is recommended. |
| Keywords | SIN-1 Chloride | SIN1 Chloride | SIN 1 Chloride | Linsidomine Hydrochloride | DrugMetabolite | Drug Metabolite |
| Inhibitors Related | Nortriptyline hydrochloride | Clofibric acid | Oseltamivir acid | Mycophenolate Mofetil | Clozapine N-Oxide | Monomethyl fumarate | Monobutyl Phthalate | Isonicotinic acid | Ampyrone | 4-Methylamino antipyrine | Nicotinamide N-oxide | DP-1 hydrochloride |
| Related Compound Libraries | Bioactive Compound Library | Anti-Cardiovascular Disease Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $2.00/100kg |
VIP1Y
|
ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD
|
2025-06-19 | |
| $0.00/1kg |
VIP4Y
|
Wuhan Senwayer Century Chemical Co.,Ltd
|
2022-10-28 | |
| $1.00/1mg |
ANHUI SHENGZHIKAI BIOTECHNOLOGY CO.,LTD
|
2022-05-31 | ||
| $0.00/1KG |
VIP4Y
|
Henan Aochuang Chemical Co.,Ltd.
|
2022-09-14 | |
| $1.00/1KG |
VIP6Y
|
Career Henan Chemical Co
|
2019-12-25 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY